Efficacy of quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine (GARDASIL) in Japanese women aged 18-26 years.
about
HPV catch-up vaccination of young women: a systematic review and meta-analysis.Association between free testosterone levels and anal human papillomavirus types 16/18 infections in a cohort of men who have sex with menImmunogenicity of quadrivalent HPV and combined hepatitis A and B vaccine when co-administered or administered one month apart to 9-10 year-old girls according to 0-6 month schedule.Literature review of vaccine-related adverse events reported from HPV vaccination in randomized controlled trialsQuadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (gardasil(®)): a review of its use in the prevention of premalignant anogenital lesions, cervical and anal cancers, and genital warts.Recent progress in vaccination against human papillomavirus-mediated cervical cancer.Serious adverse events after HPV vaccination: a critical review of randomized trials and post-marketing case series.Human papillomavirus vaccine efficacy in the prevention of anogenital warts: systematic review and meta-analysis.
P2860
Q34157209-AC5E20AF-1E78-4B3F-AA56-E1EA6F0D6643Q35203345-2C68D5CF-3CC7-433F-B4B3-7E77CFF34410Q36978399-CFEB5BDC-19E8-4DBD-AFF5-93C227488DBAQ37425284-BF5EBB7A-D9D8-4A0A-96EC-7E21601B16EBQ38229304-D8DFA4FE-AB55-428A-AB7B-24A53EF8EDB1Q38370782-5720C497-7E4C-4B88-BF8F-FAD76C57FBD8Q38668821-17FBB508-B413-4994-9780-B4B6E660FD08Q39250694-38EA462E-A6BD-4F6A-81A1-2EB9CAE6E733
P2860
Efficacy of quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine (GARDASIL) in Japanese women aged 18-26 years.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Efficacy of quadrivalent human ...... panese women aged 18-26 years.
@en
Efficacy of quadrivalent human ...... panese women aged 18-26 years.
@nl
type
label
Efficacy of quadrivalent human ...... panese women aged 18-26 years.
@en
Efficacy of quadrivalent human ...... panese women aged 18-26 years.
@nl
prefLabel
Efficacy of quadrivalent human ...... panese women aged 18-26 years.
@en
Efficacy of quadrivalent human ...... panese women aged 18-26 years.
@nl
P2093
P2860
P356
P1433
P1476
Efficacy of quadrivalent human ...... panese women aged 18-26 years.
@en
P2093
Hiroyuki Yoshikawa
Keiko Ebihara
Kiichiro Noda
Yoshiyuki Tanaka
P2860
P304
P356
10.1111/CAS.12106
P577
2013-03-07T00:00:00Z